Free Trial
→ Every Starlink dish pays this stock (From Behind the Markets) (Ad)tc pixel
NASDAQ:RKDA

Arcadia Biosciences Q3 2026 Earnings Date & Estimates

Arcadia Biosciences logo
$0.17 +0.00 (+0.12%)
As of 01:46 PM Eastern

Arcadia Biosciences is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Arcadia Biosciences in Q3 2026

Arcadia Biosciences is expected to post earnings of -$0.46 per share on revenue of $2.40 million. In the same quarter a year earlier Arcadia Biosciences reported $0.62 per share on revenue of $1.30 million. Arcadia Biosciences last reported on August 13, 2026, posting -$2.09 per share and missing the -$0.56 consensus estimate. Arcadia Biosciences has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.46
Expected Revenue
$2.40 million
Prior-Year EPS
$0.62
Prior-Year Revenue
$1.30 million
Expected EPS Growth
-174.2%
Expected Revenue Growth
+84.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$2.09 (Missed by -$1.53)
Last Quarter Revenue
$1.44 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Arcadia Biosciences Q3 2026 Earnings FAQ

Arcadia Biosciences (NASDAQ:RKDA) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Arcadia Biosciences' Q3 2026 earnings conference call is scheduled for Thursday, November 19, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Arcadia Biosciences to post earnings of -$0.46 per share for Q3 2026.

The consensus revenue estimate for Arcadia Biosciences is $2.40 million for Q3 2026.

Arcadia Biosciences Earnings Headlines

Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344934/35730/en/arcadia-biosciences-rkda-announces-second-quarter-and-first-half-2026-financial-results-and-business-highlights.html
RKDA Share News Today
July 6, 2026  |  uk.investing.comhttps://uk.investing.com/equities/arcadia-biosciences-news/9
My prediction for December 8th
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
November 10 at 1:00 AM  |  Behind the Markets (Ad)
Arcadia Biosciences, Inc.: Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 13, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68758917-arcadia-biosciences-inc-arcadia-biosciences-rkda-announces-closing-of-dollar-4-million-private-placement-priced-at-the-market-under-nasdaq-rules-399.htm
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options
June 12, 2026  |  quiverquant.comQ
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/13/3311368/35730/en/arcadia-biosciences-rkda-announces-closing-of-4-million-private-placement-priced-at-the-market-under-nasdaq-rules.html
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.

Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients. Arcadia has also pursued additional crop and ingredient technologies addressing areas such as improved nutrition, sustainability and agricultural productivity.

Founded in 2002 and headquartered in Davis, California, Arcadia has historically operated through research, product development, licensing and commercialization activities in the agricultural and food sectors. Its products and technologies have been marketed primarily in the United States, with potential applications for broader food and agricultural markets.

View Arcadia Biosciences Profile
Earnings Tools